According to the most recent analysis by Emergen Research, the size of the worldwide soft tissue repair market reached USD 14.46 billion in 2021 and is projected to grow at a revenue CAGR of 4.6% during the forecast period. Some of the major factors influencing the market’s revenue growth are the rising prevalence of chronic soft tissue trauma injuries, the popularity of minimally invasive therapies, the availability of board-certified healthcare professionals, and the quick development of tissue reengineering techniques.
Soft tissue healing, which entails the phases of regeneration and repair, is the process by which the body replaces injured tissue with healthy tissue.
Materials used to repair soft tissues including muscles, fascia, blood vessels, or other supporting connective tissues are known as soft tissue repair materials. Because it is possible to create structures that closely mimic the composition and structural properties of target tissue and that exhibit outstanding bioactivity, significant efforts are being undertaken to employ biomaterials for a variety of applications in soft tissue regeneration. Additionally, one of the major factors boosting this industry’s growth is the increasing frequency of chronic soft tissue trauma injuries. Osteoarthritis, along with other illnesses that affect the muscles, tendons, and ligaments, can make moving painful and restrict one’s ability to exercise.
Overexertion causes 34% of all job injuries, according to the Bureau of Labor Statistics. Sprains, strains, and tears, often known as soft-tissue injuries or musculoskeletal injuries, account for 43% of injuries.
The major companies Covered in the report are:
include Allergan, plc., Zimmer Biomet., CryoLife, Inc., Integra LifeSciences, LifeCell International Pvt Ltd., Smitt+Nephew., Wright Medical Group N.V., Johnson & Johnson., Stryker., and Organogenesis Inc.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.emergenresearch.com/request-sample/1445
Rapid technological developments in tissue reengineering procedures are a current market trend that are gaining popularity as a way to get around limitations of conventional treatment methods such invasiveness, post-operative issues, and volume loss. The three main causes of soft tissue damage are congenital deformity, trauma, disease, or surgical excision. Biological replacements can be produced using autologous cells, such as mesenchymal stem cells, and biomaterials that act as a support. This includes advancements in biocompatible biomaterials that can promote the regeneration of soft tissue.
Increasing prevalence of orthopedic conditions is anticipated to amplify the market statistics
It is projected that rising rates of orthopaedic disorders will boost market data.
One of the main factors propelling the global market for soft tissue repair is the rising prevalence of orthopaedic diseases. Approximately 50% of the 33 million musculoskeletal injuries recorded in the United States each year include soft tissue damage, such as tears in tendons and ligaments. Because they make it easy to fixate soft tissue quickly and effectively, suture anchors are frequently used to join tendons and ligaments—as well as other types of soft tissue—to the bone.
As a result, producers of suture anchors are constantly working to create products that are both safer and more effective. For soft tissue-to-bone fixation during anterior cruciate ligament (ACL) reconstruction, interference screws are another common way of fixation.
Custom Requirements can be requested for this Report [Customization Available]@ https://www.emergenresearch.com/request-for-customization/1445
Some Significant Report Highlights
In 2021, the segment with the highest revenue share was tissue mesh/patches. In the medical field, tissue biologic matrices are just now becoming commonplace in surgery. Due to advancements in technology and the utilisation of tissue grafts, both elective and non-elective tendon surgical therapies now have a higher success rate. Both autologous grafting and synthetic mesh products have the option of using biologic grafts made from human cadavers (allografts) and non-human animals (xenografts), such as cows or pigs, before being sterilised using various proprietary processing techniques. These are the main elements influencing this segment’s growth.
Throughout the projected period, the breast reconstruction market is anticipated to expand at a constant CAGR.
In 2021, the Europe market represented a sizeable portion of total sales. This is due to an increase in research and development (R&D) activities, increased funding from major corporations, partnerships, a supportive regulatory environment for devices for soft tissue repair, alluring government-introduced medical reimbursement policies, and the presence of an established healthcare infrastructure.
Becton, Dickinson and Company purchased Tepha, Inc. on May 28, 2021, a significant American developer and manufacturer of a novel resorbable polymer technology (BD). Through this transaction, Tepha provides BD’s current PhasixTM Mesh products and Tepha’s GalaFLEX portfolio, which is also based on the innovative P4HB polymer, with essential vertical supply chain integration.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/soft-tissue-repair-market
Emergen Research has segmented the global soft tissue repair market on product type, application, end-use, and region:
- Product Type Outlook (Revenue, USD Billion; 2019-2030)
- Tissue Mesh/Patches
- Biological Mesh
- Synthetic Mesh
- Biological Mesh
- Tissue Fixation Devices
- Tissue Mesh/Patches
- Suture Anchors
- Interference Screw
- Laparoscopic Instruments
- Application Outlook (Revenue, USD Billion; 2019-2030)
- Breast Reconstruction
- Skin Repair
- Orthopedic Repair
- Dental Repair
- Hernia Repair
- Dural Repair
- End-Use Outlook (Revenue, USD Billion; 2019-2030)
- Regional Outlook (Revenue, USD Billion; 2019-2030)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- North America
Latest Research Reports Published by Emergen Research:
Radiation Dose Management Market
Pediatric Psoriasis Market
Pulse Oximeter Market
In-Vitro Diagnostics Market
Neuromorphic Processing Market
Multiple Sclerosis Drugs Market
Metastatic Cancer Treatment Market
Clinical Perinatal Software Market
Nerve Repair And Regeneration Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read our Press Release @ https://www.emergenresearch.com/press-releases
Latest reports| Water Treatment Chemicals Market | Neuromorphic Processing Market
Trending Titles| Voice Biometrics Market| Alopecia Market